Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/500126 stock hub

BOM/500126 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/500126is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

88.8B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/500126

In the news

Latest news · BOM/500126

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.2

P25 n/aP50 n/aP75 n/a

Trailing P/E30.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC83

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/500126 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,326
Employees Change	-10%
Employees Change Percent	-0.75
Enterprise value	INR 86B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 88.8B
Price	INR 5,351
Price currency	INR
Rev Per Employee	10,169,758.67x
Sic	2834
Symbol	bom/500126
Website	https://www.pghealthindia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.3%
EV Earnings	29.31x
EV/EBIT	22.67x
EV/EBITDA	21.67x
EV/Sales	6.38x
Forward P/E	28.23x
P/B ratio	14.33x
P/E ratio	30.3x
P/S ratio	6.59x
PE Ratio10 Y	32.44x
PE Ratio3 Y	36.4x
PE Ratio5 Y	38.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.14%
EBITDA Margin	29.24%
Gross margin	71.95%
Gross Profit	INR 9.7B
Gross Profit Growth	16.8%
Gross Profit Growth Q	12.82%
Gross Profit Growth3 Y	4.33%
Gross Profit Growth5 Y	9.57%
Net Income	INR 2.9B
Net Income Growth	24.06%
Net Income Growth Q	-14.64%
Net Income Growth3 Y	6.82%
Net Income Growth5 Y	9.27%
Pretax Margin	29.3%
Profit Margin	21.76%
Profit Per Employee	INR 2.2M
ROIC	82.95
Roic5y	68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	27.11%
Cagr15y	18.37%
Cagr1y	10.14%
Cagr20y	15.04%
Cagr3y	7.94%
Cagr5y	1.28%
Div CAGR10	39.21%
Div CAGR3	53.66%
Div CAGR5	-2.28%
EPS Growth	23.98
EPS Growth Q	-14.65
EPS Growth3 Y	6.77
EPS Growth5 Y	9.25
Revenue Growth	16.3x
Revenue Growth Q	20.69x
Revenue Growth3 Y	3.27x
Revenue Growth5 Y	7.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.9B
Debt	INR 62M
Debt EBITDA	INR 0.02
Debt Equity	INR 0.01
Equity	INR 6.2B
Interest Coverage	807.4
Net Cash	INR 2.8B
Net Cash By Market Cap	INR 3.15
Net Debt EBITDA	INR -0.71
Net Debt Equity	INR -0.45
Tangible Book Value	INR 6.2B
Tangible Book Value Per Share	INR 373
WACC	5.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	46.43%
Dividend Growth Years	0%
Dividend per share	INR 125
Dividend Years	14
Dividend Yield	2.34%
Ex Div Date	2026-02-12
Last Dividend	INR 160
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,000.98%
1Y total return	10.13%
200-day SMA	5,671.3
3Y total return	25.76%
50-day SMA	4,988.4
50-day SMA vs 200-day SMA	50under200
5Y total return	6.55%
All Time High	7,500
All Time High Change	-28.65%
All Time High Date	2021-02-11
All Time Low	1.84
All Time Low Change	290,103.36%
All Time Low Date	1999-01-05
ATR	112.1
Beta	0.15
Beta1y	0.02
Beta2y	0.33
Ch YTD	-6.13
High	5,365
High52	6,700
High52 Date	2025-08-29
High52ch	-20.13%
Low	5,291
Low52	4,699.7
Low52 Date	2026-04-06
Low52ch	13.87%
Ma50ch	7.28%
Price vs 200-day SMA	-5.64%
RSI	68.4
RSI Monthly	49.99
RSI Weekly	51.59
Sharpe ratio	0.35x
Sortino ratio	0.82
Total Return	2.34%
Tr YTD	-3.32
Tr15y	1,154.84%
Tr1m	11.17%
Tr1w	3.91%
Tr3m	6.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.8B
Operating Income Growth	15.57
Operating Income Growth Q	-11.3
Operating Income Growth3 Y	6.9
Operating Income Growth5 Y	11.65
Operating margin	28.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,928,360%
Shares Insiders	0.04%
Shares Institutions	17.41%
Shares Out	16,599,382
Shares Qo Q	0.01%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,000.1x
Bv Per Share	373.3
Ch10y	700.2
Ch15y	779.4
Ch1m	11.17
Ch1w	3.91
Ch1y	6.16
Ch20y	767
Ch3m	3.03
Ch3y	12.63
Ch5y	-8.83
Ch6m	-8.28
Change	0.7%
Change From Open	0.87
Close	5,314.3
Days Gap	-0.18
Depreciation Amortization	147,933,251
Dollar Volume	4,254,323.3
Earnings Date	2026-05-26
EBIT	INR 3.8B
EBITDA	INR 3.9B
EPS	INR 177
F Score	2
Fiscal Year End	March
Founded	1,967
Graham Number	1217.97099
Graham Upside	-77.24
Income Tax	INR 1B
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Lynch Fair Value	INR 1,637
Lynch Upside	-69.41
Ma150	5,489.2
Ma150ch	-2.51%
Ma20	5,111.4
Ma20ch	4.69%
Next Earnings Date	2026-05-26
Open	5,305
Payment Date	2026-03-04
Position In Range	81.55
Price Date	2026-05-08
Price EBITDA	INR 22.53
Ptbv Ratio	14.35
Relative Volume	0.79x
Revenue	13,485,100,000x
Tax By Revenue	7.54x
Tax Rate	25.73%
Tr20y	1,547.18%
Tr6m	-5.53%
Volume	795

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/500126 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$125 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-2.3%

0 consecutive years of growth

Total shareholder yield

+2.3%

Next ex-dividend date: 2026-02-12

Performance

BOM/500126 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/500126?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.4%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BOM/500126 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.4

Neutral momentum band

Price vs 200-day MA

-5.6%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/500126

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/500126 stock rating?

bom/500126 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/500126 analysis?

The full report lives at /stocks/bom/500126/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/500126?

The latest report frames bom/500126 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/500126 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.